Page last updated: 2024-11-04

sulfinpyrazone and Centriacinar Emphysema

sulfinpyrazone has been researched along with Centriacinar Emphysema in 2 studies

Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.

Research Excerpts

ExcerptRelevanceReference
" None of the drugs inhibited chemotaxis in a dose-response fashion at concentrations achievable in human plasma."1.28Search for drugs that may reduce the load of neutrophil azurophilic granule enzymes in the lungs of patients with emphysema. ( Cohen, AB; Miller, EJ; Stevens, MD, 1989)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Keller, R1
Stevens, MD1
Miller, EJ1
Cohen, AB1

Reviews

1 review available for sulfinpyrazone and Centriacinar Emphysema

ArticleYear
[Adult respiratory distress syndrome (ARDS) (author's transl)].
    Praxis und Klinik der Pneumologie, 1981, Volume: 35, Issue:4

    Topics: Adrenal Cortex Hormones; Alkalosis; Barotrauma; Humans; Hypoxia; Myocardial Infarction; Positive-Pre

1981

Other Studies

1 other study available for sulfinpyrazone and Centriacinar Emphysema

ArticleYear
Search for drugs that may reduce the load of neutrophil azurophilic granule enzymes in the lungs of patients with emphysema.
    Experimental lung research, 1989, Volume: 15, Issue:4

    Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Chemotaxis; Glucuronidase; Humans

1989